Publications and Research Notes
KEI publishes research and commentary in a variety of journals, periodicals, books and other independent publishing platforms. In-house, KEI publishes the open journal Knowledge Ecology Studies, and presents information in blogs, correspondence and reports, as well as in occasional KEI research notes and papers.
KEI Policy Briefs
2014:1 KEI Policy Brief: Nonvoluntary use of patents for drugs to treat the Hepatitis C Virus in the United States: Mechanisms available to the Federal Government, State Governments and Private Actors. July 18, 2014
KEI Research Notes
2014:1 KEI Research Note: Recent European Union Compulsory Licenses. March 1, 2014
2014:2 KEI Research Note: Recent United States Compulsory Licenses. March 7, 2014
2014:3 Elizabeth Rajasingh, KEI Research Note: Size of Clinical Trials, data from the FDA 2010 NME and BLA approvals, preliminary results. 17 November 2014
2011:2 Tedmund Wan. Survey of drug prices for 14 drugs with US government rights in patents listed in the FDA Orange Book.
2011:1. Paul Miano. Cancer: Approval, ownership, market structure, and placement on WHO Model Essential Medicines List, for 100 new molecular entities (NMEs) on the NCI alpha list of cancer drugs and vaccines.
2010:4 Anne Mira Guha, Prices for Abbott's Norvir (generic name Ritonavir) as a Standalone Product in 2010.
2010:1 James Love, Comments on ACTA Provisions on Injunctions and Damages.
2008:3 Jacqueline Lee, Research and Development Related to dasatinib (Sprycel-tm).
2007:6 David Serafino. Survey of Patent Pools Demonstrates Variety of Purposes and Management Structures.
2007:2 James Love. Recent examples of the use of compulsory licenses on patents.
KEI Research Papers
2007:1. James Love and Tim Hubbard The Big Idea: Prizes to Stimulate R&D for New Medicines.
2006:1. Judit Rius Sanjuan, James Love and Robert Weissman, Protection of Pharmaceutical Test Data: A Policy Proposal.